<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36036324</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1420-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>79</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>29</Day></PubDate></JournalIssue><Title>Cellular and molecular life sciences : CMLS</Title><ISOAbbreviation>Cell Mol Life Sci</ISOAbbreviation></Journal><ArticleTitle>The contribution of proteasomal impairment to autophagy activation by C9orf72 poly-GA aggregates.</ArticleTitle><Pagination><StartPage>501</StartPage><MedlinePgn>501</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00018-022-04518-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Poly-GA, a dipeptide repeat protein unconventionally translated from GGGGCC (G4C2) repeat expansions in C9orf72, is abundant in C9orf72-related amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) (C9orf72-ALS/FTD). Although the poly-GA aggregates have been identified in C9orf72-ALS/FTD neurons, the effects on UPS (ubiquitin-proteasome system) and autophagy and their exact molecular mechanisms have not been fully elucidated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Herein, our in vivo experiments indicate that the mice expressing ploy-GA with 150 repeats instead of 30 repeats exhibit significant aggregates in cells. Mice expressing 150 repeats ploy-GA shows behavioral deficits and activates autophagy in the brain. In vitro findings suggest that the poly-GA aggregates influence proteasomal by directly binding proteasome subunit PSMD2. Subsequently, the poly-GA aggregates activate phosphorylation and ubiquitination of p62 to recruit autophagosomes. Ultimately, the poly-GA aggregates lead to compensatory activation of autophagy. In vivo studies further reveal that rapamycin (autophagy activator) treatment significantly improves the degenerative symptoms and alleviates neuronal injury in mice expressing 150 repeats poly-GA. Meanwhile, rapamycin administration to mice expressing 150 repeats poly-GA reduces neuroinflammation and aggregates in the brain.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In summary, we elucidate the relationship between poly-GA in the proteasome and autophagy: when poly-GA forms complexes with the proteasome, it recruits autophagosomes and affects proteasome function. Our study provides support for further promoting the comprehension of the pathogenesis of C9orf72, which may bring a hint for the exploration of rapamycin for the treatment of ALS/FTD.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pu</LastName><ForeName>Mei</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Drug Safety Evaluation and Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Life Science and Technology, ShanghaiTech University, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tai</LastName><ForeName>Yusi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center for Drug Safety Evaluation and Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Luyang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Receptor Research, Department of Neuropharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Huijie</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Drug Safety Evaluation and Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Life Science and Technology, ShanghaiTech University, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hao</LastName><ForeName>Zongbing</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neuropathology, Jiangsu Key Laboratory of Neuropsychiatric Diseases and Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Drug Safety Evaluation and Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Xinming</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Center for Drug Safety Evaluation and Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Guanghui</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neuropathology, Jiangsu Key Laboratory of Neuropsychiatric Diseases and Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu, China. wanggh@suda.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tao</LastName><ForeName>Zhouteng</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0001-9178-0740</Identifier><AffiliationInfo><Affiliation>Center for Drug Safety Evaluation and Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai, China. taozhouteng@simm.ac.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Transient Optics and Photonics, Xi'an Institute of Optics and Precision Mechanics, Chinese Academy of Sciences, Xi'an, China. taozhouteng@simm.ac.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Drug Safety Evaluation and Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai, China. jren@cdser.simm.ac.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Life Science and Technology, ShanghaiTech University, Shanghai, China. jren@cdser.simm.ac.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Chinese Academy of Sciences, Beijing, China. jren@cdser.simm.ac.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, China. jren@cdser.simm.ac.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>21DZ2291100</GrantID><Agency>Science and Technology Innovation Plan Of Shanghai Science and Technology Commission</Agency><Country/></Grant><Grant><GrantID>21ZR1475100</GrantID><Agency>Science and Technology Innovation Plan Of Shanghai Science and Technology Commission</Agency><Country/></Grant><Grant><GrantID>SIMM2103ZZ-01</GrantID><Agency>State Key Laboratory of Drug Research</Agency><Country/></Grant><Grant><GrantID>ZYYCXTD-D-202210</GrantID><Agency>Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cell Mol Life Sci</MedlineTA><NlmUniqueID>9705402</NlmUniqueID><ISSNLinking>1420-682X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.25.1</RegistryNumber><NameOfSubstance UI="D046988">Proteasome Endopeptidase Complex</NameOfSubstance></Chemical><Chemical><RegistryNumber>W36ZG6FT64</RegistryNumber><NameOfSubstance UI="D020123">Sirolimus</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D046988" MajorTopicYN="N">Proteasome Endopeptidase Complex</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020123" MajorTopicYN="N">Sirolimus</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Autophagy</Keyword><Keyword MajorTopicYN="N">C9orf72</Keyword><Keyword MajorTopicYN="N">Poly-GA</Keyword><Keyword MajorTopicYN="N">Proteasome</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36036324</ArticleId><ArticleId IdType="doi">10.1007/s00018-022-04518-5</ArticleId><ArticleId IdType="pii">10.1007/s00018-022-04518-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>DeJesus-Hernandez M et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72(2):245&#x2013;256</Citation><ArticleIdList><ArticleId IdType="pubmed">21944778</ArticleId><ArticleId IdType="pmc">3202986</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE et al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72(2):257&#x2013;268</Citation><ArticleIdList><ArticleId IdType="pubmed">21944779</ArticleId><ArticleId IdType="pmc">3200438</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler AR et al (2014) C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature 507(7491):195&#x2013;200</Citation><ArticleIdList><ArticleId IdType="pubmed">24598541</ArticleId><ArticleId IdType="pmc">4046618</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K et al (2013) Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol 126(6):881&#x2013;893</Citation><ArticleIdList><ArticleId IdType="pubmed">24132570</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K et al (2013) The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science 339(6125):1335&#x2013;1338</Citation><ArticleIdList><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR et al (2013) Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations. Acta Neuropathol 126(6):859&#x2013;879</Citation><ArticleIdList><ArticleId IdType="pubmed">24096617</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR et al (2015) Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers. Acta Neuropathol 130(6):845&#x2013;861</Citation><ArticleIdList><ArticleId IdType="pubmed">26374446</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S et al (2014) C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science 345(6201):1192&#x2013;1194</Citation><ArticleIdList><ArticleId IdType="pubmed">25103406</ArticleId><ArticleId IdType="pmc">4944841</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao Z et al (2015) Nucleolar stress and impaired stress granule formation contribute to C9orf72 RAN translation-induced cytotoxicity. Hum Mol Genet 24(9):2426&#x2013;2441</Citation><ArticleIdList><ArticleId IdType="pubmed">25575510</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ et al (2014) Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress. Acta Neuropathol 128(4):505&#x2013;524</Citation><ArticleIdList><ArticleId IdType="pubmed">25173361</ArticleId><ArticleId IdType="pmc">4159567</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ et al (2016) C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins. Nat Neurosci 19(5):668&#x2013;677</Citation><ArticleIdList><ArticleId IdType="pubmed">26998601</ArticleId><ArticleId IdType="pmc">5138863</ArticleId></ArticleIdList></Reference><Reference><Citation>Schludi MH et al (2017) Spinal poly-GA inclusions in a C9orf72 mouse model trigger motor deficits and inflammation without neuron loss. Acta Neuropathol 134(2):241&#x2013;254</Citation><ArticleIdList><ArticleId IdType="pubmed">28409281</ArticleId><ArticleId IdType="pmc">5508040</ArticleId></ArticleIdList></Reference><Reference><Citation>Gijselinck I et al (2016) The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter. Mol Psychiatry 21(8):1112&#x2013;1124</Citation><ArticleIdList><ArticleId IdType="pubmed">26481318</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying Z et al (2009) Gp78, an ER associated E3, promotes SOD1 and ataxin-3 degradation. Hum Mol Genet 18(22):4268&#x2013;4281</Citation><ArticleIdList><ArticleId IdType="pubmed">19661182</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J et al (2018) Inhibition of p70 S6 kinase activity by A77 1726 induces autophagy and enhances the degradation of superoxide dismutase 1 (SOD1) protein aggregates. Cell Death Dis. https://doi.org/10.1038/s41419-018-0441-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0441-0</ArticleId><ArticleId IdType="pubmed">30584257</ArticleId><ArticleId IdType="pmc">6315035</ArticleId></ArticleIdList></Reference><Reference><Citation>Samant RS et al (2018) Distinct proteostasis circuits cooperate in nuclear and cytoplasmic protein quality control. Nature 563(7731):407&#x2013;411</Citation><ArticleIdList><ArticleId IdType="pubmed">30429547</ArticleId><ArticleId IdType="pmc">6707801</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao JH et al (2015) mTOR inhibition activates overall protein degradation by the ubiquitin proteasome system as well as by autophagy. Proc Natl Acad Sci USA 112(52):15790&#x2013;15797</Citation><ArticleIdList><ArticleId IdType="pubmed">26669439</ArticleId><ArticleId IdType="pmc">4703015</ArticleId></ArticleIdList></Reference><Reference><Citation>Finley D (2009) Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem 78:477&#x2013;513</Citation><ArticleIdList><ArticleId IdType="pubmed">19489727</ArticleId><ArticleId IdType="pmc">3431160</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins GA, Goldberg AL (2017) The logic of the 26S proteasome. Cell 169(5):792&#x2013;806</Citation><ArticleIdList><ArticleId IdType="pubmed">28525752</ArticleId><ArticleId IdType="pmc">5609836</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N, Komatsu M (2011) Autophagy: renovation of cells and tissues. Cell 147(4):728&#x2013;741</Citation><ArticleIdList><ArticleId IdType="pubmed">22078875</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N (2007) Autophagy: process and function. Genes Dev 21(22):2861&#x2013;2873</Citation><ArticleIdList><ArticleId IdType="pubmed">18006683</ArticleId></ArticleIdList></Reference><Reference><Citation>Pankiv S et al (2007) p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282(33):24131&#x2013;24145</Citation><ArticleIdList><ArticleId IdType="pubmed">17580304</ArticleId></ArticleIdList></Reference><Reference><Citation>Waite KA et al (2016) Starvation induces proteasome autophagy with different pathways for core and regulatory particles. J Biol Chem 291(7):3239&#x2013;3253</Citation><ArticleIdList><ArticleId IdType="pubmed">26670610</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Q et al (2017) Antibodies inhibit transmission and aggregation of C9orf72 poly-GA dipeptide repeat proteins. EMBO Mol Med 9(5):687&#x2013;702</Citation><ArticleIdList><ArticleId IdType="pubmed">28351931</ArticleId><ArticleId IdType="pmc">5412769</ArticleId></ArticleIdList></Reference><Reference><Citation>Edbauer D (2016) Poly-GA initiates the disease cascade in C9orf72 FTLD/ALS. J Neurochem 138:252&#x2013;252</Citation></Reference><Reference><Citation>Deverman BE et al (2016) Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain. Nat Biotechnol 34(2):204&#x2013;209</Citation><ArticleIdList><ArticleId IdType="pubmed">26829320</ArticleId><ArticleId IdType="pmc">5088052</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan KY et al (2017) Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat Neurosci 20(8):1172&#x2013;1179</Citation><ArticleIdList><ArticleId IdType="pubmed">28671695</ArticleId><ArticleId IdType="pmc">5529245</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley ME, Baloh RH (2019) Inflammation in ALS/FTD pathogenesis. Acta Neuropathol 137(5):715&#x2013;730</Citation><ArticleIdList><ArticleId IdType="pubmed">30465257</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma XY et al (2022) CCT2 is an aggrephagy receptor for clearance of solid protein aggregates. Cell 185(8):1325&#x2013;1345</Citation><ArticleIdList><ArticleId IdType="pubmed">35366418</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai Y et al (1999) Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum Mol Genet 8(4):673&#x2013;682</Citation><ArticleIdList><ArticleId IdType="pubmed">10072437</ArticleId></ArticleIdList></Reference><Reference><Citation>Bence NF, Sampat RM, Kopito RR (2001) Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292(5521):1552&#x2013;1555</Citation><ArticleIdList><ArticleId IdType="pubmed">11375494</ArticleId></ArticleIdList></Reference><Reference><Citation>Neefjes J, Dantuma NP (2004) Fluorescent probes for proteolysis: Tools for drug discovery. Nat Rev Drug Discov 3(1):58&#x2013;69</Citation><ArticleIdList><ArticleId IdType="pubmed">14708021</ArticleId><ArticleId IdType="pmc">7097193</ArticleId></ArticleIdList></Reference><Reference><Citation>Juszkiewicz S, Hegde RS (2018) Quality control of orphaned proteins. Mol Cell 71(3):443&#x2013;457</Citation><ArticleIdList><ArticleId IdType="pubmed">30075143</ArticleId><ArticleId IdType="pmc">6624128</ArticleId></ArticleIdList></Reference><Reference><Citation>Bett JS (2016) Proteostasis regulation by the ubiquitin system. Proteostasis 60(2):143&#x2013;151</Citation></Reference><Reference><Citation>Cohen-Kaplan V et al (2016) p62-and ubiquitin-dependent stress-induced autophagy of the mammalian 26S proteasome. Proc Natl Acad Sci USA 113(47):E7490&#x2013;E7499</Citation><ArticleIdList><ArticleId IdType="pubmed">27791183</ArticleId><ArticleId IdType="pmc">5127335</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawaguchi Y et al (2003) The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115(6):727&#x2013;738</Citation><ArticleIdList><ArticleId IdType="pubmed">14675537</ArticleId></ArticleIdList></Reference><Reference><Citation>McNaught KSP et al (2002) Aggresome-related biogenesis of Lewy bodies. Eur J Neurosci 16(11):2136&#x2013;2148</Citation><ArticleIdList><ArticleId IdType="pubmed">12473081</ArticleId></ArticleIdList></Reference><Reference><Citation>Boughton AJ et al (2021) Polyubiquitin and ubiquitin-like signals share common recognition sites on proteasomal subunit Rpn1. J Biol Chem 296:100450</Citation><ArticleIdList><ArticleId IdType="pubmed">33617881</ArticleId><ArticleId IdType="pmc">8008175</ArticleId></ArticleIdList></Reference><Reference><Citation>Kliosnky D (2016) Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (vol 12, pg 1, 2015). Autophagy 12(2):443</Citation></Reference><Reference><Citation>Li X et al (2021) Annexin-A1 SUMOylation regulates microglial polarization after cerebral ischemia by modulating IKK alpha stability via selective autophagy. Sci Adv. https://doi.org/10.1126/sciadv.abc5539</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abc5539</ArticleId><ArticleId IdType="pubmed">34936449</ArticleId><ArticleId IdType="pmc">8694622</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo H et al (2020) Nuclear miR-30b-5p suppresses TFEB-mediated lysosomal biogenesis and autophagy. Cell Death Differ 28(1):320&#x2013;336</Citation><ArticleIdList><ArticleId IdType="pubmed">32764647</ArticleId><ArticleId IdType="pmc">7853097</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanji K et al (2014) Phosphorylation of serine 349 of p62 in Alzheimer&#x2019;s disease brain. Acta Neuropathologica Commun. https://doi.org/10.1186/2051-5960-2-50</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-2-50</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto G et al (2011) Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. Mol Cell 44(2):279&#x2013;289</Citation><ArticleIdList><ArticleId IdType="pubmed">22017874</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilli M et al (2012) TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation. Immunity 37(2):223&#x2013;234</Citation><ArticleIdList><ArticleId IdType="pubmed">22921120</ArticleId><ArticleId IdType="pmc">3428731</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichimura Y et al (2013) Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. Mol Cell 51(5):618&#x2013;631</Citation><ArticleIdList><ArticleId IdType="pubmed">24011591</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y et al (2016) Rpn1 provides adjacent receptor sites for substrate binding and deubiquitination by the proteasome. Science. https://doi.org/10.1126/science.aad9421</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad9421</ArticleId><ArticleId IdType="pubmed">27980089</ArticleId><ArticleId IdType="pmc">5476369</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciechanover A, Kwon YT (2015) Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp Mol Med 47(3):e147</Citation><ArticleIdList><ArticleId IdType="pubmed">25766616</ArticleId><ArticleId IdType="pmc">4351408</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen-Kaplan V et al (2016) p62- and ubiquitin-dependent stress-induced autophagy of the mammalian 26S proteasome. Proc Natl Acad Sci USA 113(47):E7490&#x2013;E7499</Citation><ArticleIdList><ArticleId IdType="pubmed">27791183</ArticleId><ArticleId IdType="pmc">5127335</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaiho-Soma A et al (2021) TRIP12 promotes small-molecule-induced degradation through K29/K48-branched ubiquitin chains. Mol Cell 81(7):1411&#x2013;1424 (e7)</Citation><ArticleIdList><ArticleId IdType="pubmed">33567268</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerji V, Gibson SB (2012) Targeting metabolism and autophagy in the context of haematologic malignancies. Int J Cell Biol 2012:595976</Citation><ArticleIdList><ArticleId IdType="pubmed">22829831</ArticleId><ArticleId IdType="pmc">3399452</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SH et al (2013) PolyQ proteins interfere with nuclear degradation of cytosolic proteins by sequestering the Sis1p chaperone. Cell 154(1):134&#x2013;145</Citation><ArticleIdList><ArticleId IdType="pubmed">23791384</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristiansen M et al (2007) Disease-associated prion protein oligomers inhibit the 26S proteasome. Mol Cell 26(2):175&#x2013;188</Citation><ArticleIdList><ArticleId IdType="pubmed">17466621</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Q et al (2018) In situ structure of neuronal C9orf72 poly-GA aggregates reveals proteasome recruitment. Cell 172(4):696&#x2013;705</Citation><ArticleIdList><ArticleId IdType="pubmed">29398115</ArticleId><ArticleId IdType="pmc">6035389</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuervo AM et al (1995) Degradation of proteasomes by lysosomes in rat-liver. Eur J Biochem 227(3):792&#x2013;800</Citation><ArticleIdList><ArticleId IdType="pubmed">7867640</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall RS et al (2015) Autophagic degradation of the 26S proteasome is mediated by the dual ATG8/ubiquitin receptor RPN10 in Arabidopsis. Mol Cell 58(6):1053&#x2013;1066</Citation><ArticleIdList><ArticleId IdType="pubmed">26004230</ArticleId><ArticleId IdType="pmc">4903074</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu KF, Psakhye I, Jentsch S (2014) Autophagic clearance of PolyQ proteins mediated by ubiquitin-Atg8 adaptors of the conserved CUET protein family. Cell 158(3):549&#x2013;563</Citation><ArticleIdList><ArticleId IdType="pubmed">25042851</ArticleId></ArticleIdList></Reference><Reference><Citation>Kageyama S et al (2014) Proteasome dysfunction activates autophagy and the Keap1-Nrf2 pathway. J Biol Chem 289(36):24944&#x2013;24955</Citation><ArticleIdList><ArticleId IdType="pubmed">25049227</ArticleId><ArticleId IdType="pmc">4155663</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen L et al (2020) Antibody therapy targeting RAN proteins rescues C9 ALS/FTD phenotypes in C9orf72 mouse model. Neuron 105(4):645&#x2013;662</Citation><ArticleIdList><ArticleId IdType="pubmed">31831332</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K et al (2021) UBQLN2-HSP70 axis reduces poly-Gly-Ala aggregates and alleviates behavioral defects in the C9ORF72 animal model. Neuron 109(12):1949&#x2013;1962 (e6)</Citation><ArticleIdList><ArticleId IdType="pubmed">33991504</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang XJ et al (2011) Rapamycin treatment augments motor neuron degeneration in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Autophagy 7(4):412&#x2013;425</Citation><ArticleIdList><ArticleId IdType="pubmed">21193837</ArticleId></ArticleIdList></Reference><Reference><Citation>Caccamo A et al (2009) Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability. J Biol Chem 284(40):27416&#x2013;27424</Citation><ArticleIdList><ArticleId IdType="pubmed">19651785</ArticleId><ArticleId IdType="pmc">2785671</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang IF et al (2012) Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc Natl Acad Sci USA 109(37):15024&#x2013;15029</Citation><ArticleIdList><ArticleId IdType="pubmed">22932872</ArticleId><ArticleId IdType="pmc">3443184</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli J et al (2018) Rapamycin treatment for amyotrophic lateral sclerosis Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial). Medicine 97(24):e11119</Citation><ArticleIdList><ArticleId IdType="pubmed">29901635</ArticleId><ArticleId IdType="pmc">6024184</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Wang J (2019) C9orf72-dependent lysosomal functions regulate epigenetic control of autophagy and lipid metabolism. Autophagy 15(5):913&#x2013;914</Citation><ArticleIdList><ArticleId IdType="pubmed">30767689</ArticleId><ArticleId IdType="pmc">6526819</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho WY et al (2019) The ALS-FTD-linked gene product, C9orf72, regulates neuronal morphogenesis via autophagy. Autophagy 15(5):827&#x2013;842</Citation><ArticleIdList><ArticleId IdType="pubmed">30669939</ArticleId><ArticleId IdType="pmc">6526867</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M et al (2016) A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy. Sci Adv. https://doi.org/10.1126/sciadv.1601167</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.1601167</ArticleId><ArticleId IdType="pubmed">28861461</ArticleId><ArticleId IdType="pmc">5262457</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L et al (2014) p62/sequestosome 1 regulates aggresome formation of pathogenic ataxin-3 with expanded polyglutamine. Int J Mol Sci 15(9):14997&#x2013;15010</Citation><ArticleIdList><ArticleId IdType="pubmed">25158237</ArticleId><ArticleId IdType="pmc">4200763</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrow CS et al (2020) Vimentin coordinates protein turnover at the aggresome during neural stem cell quiescence exit. Cell Stem Cell 26(4):558&#x2013;568 (e9)</Citation><ArticleIdList><ArticleId IdType="pubmed">32109376</ArticleId><ArticleId IdType="pmc">7127969</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>